Keenova Therapeutics plc Long-Term Debt, Maturity, Year Five
Keenova Therapeutics plc had Long-Term Debt, Maturity, Year Five of $15.00 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2026-04-15
- 2025-12-31: Long-Term Debt, Maturity, Year Five $15.00M.
- 2025-09-26: Long-Term Debt, Maturity, Year Five $885.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2025-12-31 | $15.00M 10-K · filed 2026-04-15 |
| 2025-09-26 | $885.00M 10-Q · filed 2025-11-10 |